⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL288900 | 1.00 | — | — | |
| SCHEMBL5794333 | 1.00 | — | — | |
| SCHEMBL27974429 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL3493938 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL3493943 | 0.97 | — | — | |
| SCHEMBL27974428 | 0.97 | — | — | |
| SCHEMBL3347601 | 0.83 | — | — | |
| SCHEMBL4819961 | 0.83 | — | — | |
| SCHEMBL4820853 | 0.83 | — | — | |
| Homoserine SCHEMBL15345888 | 0.82 | GSR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115716856-B | Synthetic aminoglycoside method for antibiotic Abecamycin | 北京耀诚惠仁科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-115716856-A | Method for synthesizing aminoglycoside antibiotic arbekacin | 山东厚德精诚药业有限公司 | 2023-02-28 | — | — | CN | claimed |
| US-9833768-B2 | Affinity reagents for protein purification | IMPOSSIBLE FOODS INC. (US) | 2017-12-05 | — | — | US | claimed |
| US-20170320041-A1 | AFFINITY REAGENTS FOR PROTEIN PURIFICATION | IMPOSSIBLE FOODS INC. | 2017-11-09 | — | — | US | claimed |
| US-9737875-B2 | Affinity reagents for protein purification | IMPOSSIBLE FOODS INC. (US) | 2017-08-22 | — | — | US | claimed |
| CN-104620104-B | Affinity Reagents for Protein Purification | 非凡食品有限公司 | 2017-03-01 | — | — | CN | claimed |
| CN-104844500-A | Method for preparing amikacin intermediate through solid phase one-pot fusion method | ZHEJIANG HAISEN PHARMACY CO LTD | 2015-08-19 | — | — | CN | claimed |
| CN-102190690-B | Convenient high-yield Arbekacin synthesis method | FUZHOU BORNI PHARMACEUTICAL SCIENCE & TECHNOLOGY CO LTD | 2015-01-21 | — | — | CN | claimed |
| CN-102190690-A | Convenient high-yield Arbekacin synthesis method | FUZHOU BORNI PHARMACEUTICAL SCI & TECH CO LTD | 2011-09-21 | — | — | CN | claimed |
| US-7652152-B2 | Synthetic method of optically pure (S)-3-hydroxypyrrolidine | CHIROAD INCORPORATE (KR) | 2010-01-26 | — | — | US | claimed |
| US-20080214837-A1 | Synthetic Method of Optically Pure (S)-3-Hydroxypyrrolidine | CHIROAD INCORPORATE (KR) | 2008-09-04 | — | — | US | claimed |
| WO-2007011162-A1 | SYNTHETIC METHOD OF OPTICALLY PURE (S)-3-HYDROXYPYRROLIDINE | CHIROAD INCORPORATE (KR) | 2007-01-25 | — | — | WO | claimed |
| CN-1558898-A | Antiviral agent | ��Ұ����ҩ��ʽ���� | 2004-12-29 | — | — | CN | claimed |
| EP-1422218-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2004-05-26 | — | — | EP | claimed |
| CN-1036340-C | Alpha-hydroxy-r-amino-butyric acid synthetic process | CHENGDU PHARMACEUTICAL FACTORY (CN) | 1997-11-05 | — | — | CN | claimed |
| EP-0104125-B1 | 5,2',3',4',4\",6\"-HEXADEOXYKANAMYCIN AND ITS 1-N-ACYLATED DERIVATIVE | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1986-12-30 | — | — | EP | claimed |
| EP-0104125-A1 | 5,2',3',4',4\",6\"-Hexadeoxykanamycin and its 1-N-acylated derivative | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1984-03-28 | — | — | EP | claimed |
| US-20260146238-A1 | UREA-BASED ICE RECRYSTALLIZATION INHIBITOR COMPOUNDS AND COMPOSITIONS, AND USES THEREOF FOR CRYOPRESERVATION | PanTHERA CryoSolutions Inc. (CA) | 2026-05-28 | — | — | US | disclosed |
| US-4125706-A | Novel process for the preparation of 1-N-(alpha-substituted-omega-aminoacyl)-3'-deoxyribostamycin | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1978-11-14 | — | — | US | disclosed |
| US-4062947-A | Di-N-alkylaminoglycosides, methods for their manufacture and novel intermediates useful therein, method for their use as antibacterial agents and pharmaceutical compositions useful therefor | SCHERING CORPORATION (US) | 1977-12-13 | — | — | US | disclosed |